At Cancer Council NSW, we believe in a cancer-free future. Along with Cancer Councils across the country, we are committed to reducing the impact of cancer for generations to come.
We are proud to be one of the largest non-government funders of cancer research in Australia. We conduct and fund research studies across all cancers and all stages of the cancer journey.
Research experts, cancer patients, survivors and carers help us decide what research to fund. We assess both the scientific merit of a project and its potential impact on the community.
In 2016/17 Cancer Council NSW provided funding to support 75 world-class cancer research projects, with 301 researchers across 16 institutions.
Dr Nair-Shalliker's study also found that adult body size, sexual activity and adolescent sexual development are among the factors that appear to raise the risk of prostate cancer.
Professor Bettina Meiser is leading a world-first study on the impacts of testing women for common, low-risk genetic variants that can lead to breast cancer.
For Linda volunteering on Daffodil Day isn't just about fundraising. People just want someone to listen and I enjoy being there.
Professor De Fazio’s team is investigating a rare and treatment-resistant subtype of ovarian cancer. Their approach has a better chance of predicting which treatments will work.
There has never been a more exciting time to be doing research. We talk about ovarian cancer as one disease, but we are starting to learn that there are many different subtypes.
A research team led by Associate Professor Scott Byrne has discovered a vital mechanism that shows how cells in the immune system are hijacked by UV exposure.
This research aims to improve the health and wellbeing of the estimated one million people living with and beyond cancer, as cancer survival rates continue to increase.
Research shows that 3,900 cases of cancers each year are related to being overweight. This research helps paint a picture of the extent of unhealthy marketing to children.
One of the key ways to reduce the impact of cancer is to prevent it. Dr Veerman's team looks at risk factors to determine how we can achieve that at the lowest cost.
Cancer Council NSW researchers have evaluated the performance of a lung cancer risk tool used to predict current and ex-smokers at the highest risk of developing lung cancer.
Two research teams are making inroads into multiple myeloma treatment with the potential for both managing the symptoms of the disease and in halting tumour progress.
A novel approach to shutting down the energy supply in cancer cells has led to highly promising treatments that are already undergoing successful trials in people with solid cancer tumours.
Jane Bennett talks about representing consumers in deciding what research Cancer Council funds.
This world-first trial of cervical screening in an HPV-vaccinated population, will further increase our knowledge of Australia's new cervical cancer screening program.
Dr Jeremy Henson and his team have discovered a new way to test for aggressive cancers. The test could aid in early diagnosis and help with devising the best treatment for each patient.
Associate Professor Holst's team are working on a new type of anti-cancer drug that can ‘starve’ prostate cancer cells and stop their growth.
After losing both parents to cancer James Freeman started Sh*tbox Rally, to date raising almost $12million for cancer research.
Using the latest approaches to genomic sequencing, Associate Professor Marcel Dinger and his team are working to identify genes that contribute to rare head and neck cancers.
Dr Megan Chircop's team have found new compounds that can target the deadliest type of malignant brain tumour, glioblastoma multiforme.
This study of 9,000 participants found that physical activity has the potential to lower someone’s cancer risk regardless of their body weight.
Associate Professor Phoebe Phillips and her team have come up with a new way to target the cells that help the spread of aggressive pancreatic cancer.